---
title: Arformoterol
description: >-
  - Arformoterol is prescribed for the long-term, twice-daily (morning and
  evening) maintenance treatment of bronchoconstriction in patients with chronic
  obstructive pulmonary disease (COPD), including chronic bronchitis and
  emphysema.  It is *not* indicated for the treatment of asthma or acute epi...
is_banned: false
lastModified: '2025-09-22T17:21:52.234Z'
faqs:
  - q: >-
      What is the recommended dosage for Arformoterol?**

      **A:** The standard adult dose is 15 mcg via nebulization twice daily
      (morning and evening), not to exceed 30 mcg per day. Pediatric dosing is
      not established.
    a: >-
      A:** The standard adult dose is 15 mcg via nebulization twice daily
      (morning and evening), not to exceed 30 mcg per day. Pediatric dosing is
      not established.
  - q: >-
      Can Arformoterol be used to treat asthma?**

      **A:** No, arformoterol is not indicated for the treatment of asthma.
      Studies have shown an increased risk of asthma-related death with LABAs
      like arformoterol when used without an inhaled corticosteroid.
    a: >-
      A:** No, arformoterol is not indicated for the treatment of asthma.
      Studies have shown an increased risk of asthma-related death with LABAs
      like arformoterol when used without an inhaled corticosteroid.
  - q: >-
      How should Arformoterol be administered?**

      **A:** Arformoterol should be administered via nebulization using a
      standard jet nebulizer connected to an air compressor. It should not be
      swallowed or injected.
    a: >-
      A:** Arformoterol should be administered via nebulization using a standard
      jet nebulizer connected to an air compressor. It should not be swallowed
      or injected.
  - q: >-
      What are the most common side effects of Arformoterol?**

      **A:** Common side effects include headache, tremor, nervousness, back
      pain, chest pain, diarrhea, leg cramps, skin rash, swelling in the legs,
      stuffy nose, and flu-like symptoms.
    a: >-
      A:** Common side effects include headache, tremor, nervousness, back pain,
      chest pain, diarrhea, leg cramps, skin rash, swelling in the legs, stuffy
      nose, and flu-like symptoms.
  - q: >-
      What should be done if a patient experiences paradoxical bronchospasm
      after taking Arformoterol?**

      **A:** Paradoxical bronchospasm is a serious side effect.  Discontinue
      arformoterol immediately and seek medical attention.
    a: >-
      A:** Paradoxical bronchospasm is a serious side effect.  Discontinue
      arformoterol immediately and seek medical attention.
  - q: >-
      Can Arformoterol be used during pregnancy?**

      **A:** Arformoterol should be used during pregnancy only if the potential
      benefit justifies the potential risk to the fetus. Consult with a
      specialist.
    a: >-
      A:** Arformoterol should be used during pregnancy only if the potential
      benefit justifies the potential risk to the fetus. Consult with a
      specialist.
  - q: >-
      Are there any drug interactions with Arformoterol?**

      **A:** Yes, arformoterol can interact with several medications, including
      beta-blockers, certain antidepressants (MAOIs, TCAs), QT-prolonging drugs,
      and other bronchodilators.
    a: >-
      A:** Yes, arformoterol can interact with several medications, including
      beta-blockers, certain antidepressants (MAOIs, TCAs), QT-prolonging drugs,
      and other bronchodilators.
  - q: >-
      Can Arformoterol be used with other inhaled bronchodilators?**

      **A:** Concurrent use of arformoterol with other long-acting
      beta2-agonists is not recommended. Short-acting bronchodilators may be
      used as needed for acute symptoms.
    a: >-
      A:** Concurrent use of arformoterol with other long-acting beta2-agonists
      is not recommended. Short-acting bronchodilators may be used as needed for
      acute symptoms.
  - q: >-
      Is Arformoterol safe for patients with renal impairment?**

      **A:** Yes, no dosage adjustment is needed for patients with renal
      impairment.
    a: >-
      A:** Yes, no dosage adjustment is needed for patients with renal
      impairment.
  - q: >-
      How should Arformoterol be stored?**

      **A:** Store unopened vials in the foil pouch in the refrigerator.
      Unopened pouches may be stored at room temperature for up to six weeks.
      Once a vial is opened, use immediately.  Discard after six weeks or the
      expiry date if stored at room temperature.
    a: >-
      A:** Store unopened vials in the foil pouch in the refrigerator. Unopened
      pouches may be stored at room temperature for up to six weeks. Once a vial
      is opened, use immediately.  Discard after six weeks or the expiry date if
      stored at room temperature.
---
## **Usage**

- Arformoterol is prescribed for the long-term, twice-daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.  It is *not* indicated for the treatment of asthma or acute episodes of bronchospasm.
- **Pharmacological Classification:**  Long-acting beta2-adrenergic agonist (LABA), Bronchodilator
- **Mechanism of Action:** Arformoterol relaxes the smooth muscles in the airways, leading to bronchodilation and improved airflow to the lungs.

## **Alternate Names**

- (R,R)-formoterol
- **Brand Name:** Brovana

## **How It Works**

- **Pharmacodynamics:** Arformoterol acts as a selective agonist at beta2-adrenergic receptors, primarily in the lungs. This stimulation activates intracellular signaling pathways that lead to smooth muscle relaxation and bronchodilation.
- **Pharmacokinetics:**
    - **Absorption:**  Administered via nebulization, arformoterol is rapidly absorbed into the systemic circulation.
    - **Metabolism:** Primarily metabolized in the liver.
    - **Elimination:**  Primarily eliminated via renal excretion.
- **Mode of Action:** Binds to beta2-adrenergic receptors on airway smooth muscle cells, initiating a cascade of intracellular events culminating in bronchodilation.
- **Receptor Binding:** Selective agonist at beta2-adrenergic receptors. Minimal activity at beta1 receptors, therefore reducing cardiovascular side effects compared with non-selective beta-agonists.
- **Elimination Pathways:** Primarily renal excretion; some hepatic metabolism.

## **Dosage**

### **Standard Dosage**

#### **Adults:**

- 15 mcg administered twice daily (morning and evening) by nebulization.
- The total daily dose should not exceed 30 mcg.

#### **Children:**

- Use and dose must be determined by a doctor; safety and efficacy have not been established in pediatric patients under 18.

#### **Special Cases:**

- **Elderly Patients:** No dose adjustment is typically required.
- **Patients with Renal Impairment:** No dose adjustment required.
- **Patients with Hepatic Dysfunction:**  No dose adjustment required, but use with caution and close monitoring due to potential for prolonged systemic exposure.
- **Patients with Comorbid Conditions:** Use with caution in patients with cardiovascular disease, diabetes, hyperthyroidism, hypokalemia, seizures, and those taking other medications. 

### **Clinical Use Cases**

- Arformoterol is *not* recommended for intubation, surgical procedures, mechanical ventilation, intensive care unit (ICU) use, or emergency situations. Its long-acting nature makes it unsuitable for acute management. Short-acting bronchodilators are preferred for these settings.

### **Dosage Adjustments**

- Dosage modifications may be necessary based on individual patient response and tolerability.

## **Side Effects**

### **Common Side Effects**

- Headache, dizziness, nervousness, tremor, back pain, chest pain, diarrhea, leg cramps, skin rash, swelling in the legs, stuffy nose, flu-like symptoms, dry mouth.

### **Rare but Serious Side Effects**

- Worsening breathing problems (paradoxical bronchospasm), severe allergic reactions (hives, swelling of face, lips, tongue, or throat), fast or irregular heartbeat, chest pain, high blood sugar, low potassium levels.

### **Long-Term Effects**

- Potential long-term effects are not well-established, but chronic use of beta2-agonists has been linked to a possible increased risk of cardiovascular issues. 

### **Adverse Drug Reactions (ADR)**

- Paradoxical bronchospasm, severe allergic reactions, cardiac arrhythmias, hypokalemia.

## **Contraindications**

- Hypersensitivity to arformoterol, formoterol, or any component of the product.
- Use of a LABA without an inhaled corticosteroid is contraindicated in asthma patients.
- Asthma.

## **Drug Interactions**

- Beta-blockers, other bronchodilators, certain antidepressants (MAOIs, TCAs), drugs that prolong the QT interval (e.g. some antipsychotics, some antibiotics), diuretics (potassium loss), digoxin.

## **Pregnancy and Breastfeeding**

- **Pregnancy:** No adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus.
- **Breastfeeding:**  No recommendation from the manufacturer regarding use during lactation. While very little is expected to be excreted into breast milk, the safety of the drug for the nursing infant is not established.


## **Drug Profile Summary**

- **Mechanism of Action:**  Relaxes airway smooth muscle by stimulating beta2-adrenergic receptors.
- **Side Effects:** Headache, tremor, nervousness, worsening of breathing, allergic reactions, cardiac effects, hypokalemia.
- **Contraindications:** Hypersensitivity, asthma without concurrent ICS, acute bronchospasm.
- **Drug Interactions:** Beta-blockers, MAOIs, TCAs, QT-prolonging drugs, diuretics, other bronchodilators.
- **Pregnancy & Breastfeeding:** Use with caution; potential fetal risks; limited data on breastfeeding safety.
- **Dosage:** 15 mcg by nebulization twice daily; max 30 mcg/day.
- **Monitoring Parameters:**  Pulmonary function tests, blood pressure, heart rate, potassium levels, blood glucose.


## **Popular Combinations**

- Arformoterol is not typically used in combination with other inhaled long-acting bronchodilators. Short-acting bronchodilators (e.g., albuterol) may be used as rescue medication for acute symptoms.


## **Precautions**

- Pre-existing medical conditions: Assess patients for cardiac disease, diabetes, hyperthyroidism, hypokalemia, and seizures.
- Pregnant women: Weigh benefits against potential risks to the fetus.
- Breastfeeding mothers:  Limited data available; consider the infant's potential exposure.
- Children & Elderly: Safety and efficacy in pediatric patients not established; no specific precautions for the elderly.
- Lifestyle Considerations: Monitor for potential drug interactions with alcohol, smoking, and diet. 


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Arformoterol?**
**A:** The standard adult dose is 15 mcg via nebulization twice daily (morning and evening), not to exceed 30 mcg per day. Pediatric dosing is not established.


### **Q2: Can Arformoterol be used to treat asthma?**
**A:** No, arformoterol is not indicated for the treatment of asthma. Studies have shown an increased risk of asthma-related death with LABAs like arformoterol when used without an inhaled corticosteroid.


### **Q3: How should Arformoterol be administered?**
**A:** Arformoterol should be administered via nebulization using a standard jet nebulizer connected to an air compressor. It should not be swallowed or injected.

### **Q4: What are the most common side effects of Arformoterol?**
**A:** Common side effects include headache, tremor, nervousness, back pain, chest pain, diarrhea, leg cramps, skin rash, swelling in the legs, stuffy nose, and flu-like symptoms.

### **Q5: What should be done if a patient experiences paradoxical bronchospasm after taking Arformoterol?**
**A:** Paradoxical bronchospasm is a serious side effect.  Discontinue arformoterol immediately and seek medical attention.

### **Q6: Can Arformoterol be used during pregnancy?**
**A:** Arformoterol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult with a specialist.

### **Q7: Are there any drug interactions with Arformoterol?**
**A:** Yes, arformoterol can interact with several medications, including beta-blockers, certain antidepressants (MAOIs, TCAs), QT-prolonging drugs, and other bronchodilators.

### **Q8: Can Arformoterol be used with other inhaled bronchodilators?**
**A:** Concurrent use of arformoterol with other long-acting beta2-agonists is not recommended. Short-acting bronchodilators may be used as needed for acute symptoms.

### **Q9: Is Arformoterol safe for patients with renal impairment?**
**A:** Yes, no dosage adjustment is needed for patients with renal impairment.

### **Q10: How should Arformoterol be stored?**
**A:** Store unopened vials in the foil pouch in the refrigerator. Unopened pouches may be stored at room temperature for up to six weeks. Once a vial is opened, use immediately.  Discard after six weeks or the expiry date if stored at room temperature.
